LeBoff MS, Greenspan SL, Insogna KL, et al. American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis –2020 update. Incidence and mortality of hip fractures in the United States. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. ![]() Anabolic agents such as teriparatide, abaloparatide, and romosozumab should be considered for patients at very high risk or with previous vertebral fractures. Patients at high risk of fracture should consider treatment with antiresorptive therapy, including bisphosphonates and denosumab. Treatment of osteoporosis is influenced by the patient’s fracture risk, the effectiveness of fracture risk reduction, and medication safety. All patients with osteoporosis should be counseled on weight-bearing exercise, smoking cessation, moderation of alcohol intake, and calcium and vitamin D supplementation. Osteoporosis can be diagnosed by a T-score of −2.5 or less or the presence of a fragility fracture. Preventive Services Task Force did not find sufficient evidence to support routine screening in men. The Bone Health and Osteoporosis Foundation recommends screening men 70 years and older and men with clinical risk factors however, the U.S. Screening for osteoporosis with dual energy x-ray absorptiometry should be considered for all women 65 years and older or women who are postmenopausal with clinical risk factors. Osteoporotic fractures, specifically hip fractures, significantly affect morbidity, mortality, and quality of life. ![]() Osteoporosis affects 10.2% of adults older than 50 years and is expected to increase to 13.6% by 2030.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |